<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37346808</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>Recent Advancements on Long COVID in China: A Narrative Review.</ArticleTitle><Pagination><StartPage>2585</StartPage><EndPage>2593</EndPage><MedlinePgn>2585-2593</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S417692</ELocationID><Abstract><AbstractText>The COVID-19 pandemic is a huge public health crisis in the 21st century. In addition to the acute symptoms, a considerable proportion of patients worldwide have suffered from post-COVID-19 syndrome, commonly known as Long COVID. The impact of Long COVID on individual and public health burden cannot be ignored. According to recent researches, Long COVID has been affecting multiple organ systems throughout the body, with respiratory, mental, nervous and digestive symptoms often seen in Chinese population. Clinical studies have proved that symptoms were alleviated by a variety of treatments, such as physical therapy, rehabilitation training, psychological support, behavioral cognitive therapy, stem cell therapy, etc. Based on the current clinical evidence, it is recommended to strengthen the scientific research on Long COVID and actively carry out early monitoring and intervention in the future, so as to effectively prevent the long-term disease burden and economic pressure.</AbstractText><CopyrightInformation>&#xa9; 2023 Tang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Tiantian</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0006-3710-5131</Identifier><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guangrong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongying</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8573-8535</Identifier><AffiliationInfo><Affiliation>Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">clinical characteristics</Keyword><Keyword MajorTopicYN="N">management strategies</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37346808</ArticleId><ArticleId IdType="pmc">PMC10281791</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S417692</ArticleId><ArticleId IdType="pii">417692</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caldera-Crespo LA, Paidas MJ, Roy S, et al. Experimental models of COVID-19. Front Cell Infect Microbiol. 2022;11:792584. doi:10.3389/fcimb.2021.792584</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.792584</ArticleId><ArticleId IdType="pmc">PMC8791197</ArticleId><ArticleId IdType="pubmed">35096645</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753&#x2013;758. doi:10.1136/postgradmedj-2020-138234</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138234</ArticleId><ArticleId IdType="pmc">PMC10016932</ArticleId><ArticleId IdType="pubmed">32563999</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Center For Disease Control And Prevention. National novel coronavirus infection epidemic situation; 2023. Available from: https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202302/t20230225_263964.html. Accessed February
25, 2023.</Citation></Reference><Reference><Citation>Tan H, Liu J, Zeng F. China needs a scientific long COVID recovery-support platform. Lancet. 2023;401(10374):344&#x2013;345. doi:10.1016/S0140-6736(23)00138-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00138-1</ArticleId><ArticleId IdType="pmc">PMC9894605</ArticleId><ArticleId IdType="pubmed">36739132</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. Accessed December
07, 2022.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>covid.gov. What is Long COVID?
Available from: https://www.covid.gov/longcovid/definitions. Accessed June
14, 2023.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi:10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MC, Huang J, Wong YY, et al. Epidemiology, symptomatology, and risk factors for long COVID symptoms: population-based, multicenter study. JMIR Public Health Surveill. 2023;9:e42315. doi:10.2196/42315</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/42315</ArticleId><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. 2022;18(12):4768&#x2013;4780. doi:10.7150/ijbs.75056</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al. The conundrum of &#x2018;long-COVID-19&#x2019;: a narrative review. Int J Gen Med. 2021;14:2491&#x2013;2506. doi:10.2147/IJGM.S316708</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489. doi:10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;876. doi:10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years - United States, March 2020-November 2021. Morb Morta Weekly Rep. 2022;71(21):713. doi:10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955&#x2013;972. doi:10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>l-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi:10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The Costs of Long COVID. JAMA Health Forum. 2022;3(5):e221809. doi:10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Zhao Y, Li M, et al. Adverse effects of long COVID and its countermeasures: a review. Chin J Public Health. 2022;38(09):1229&#x2013;1232.</Citation></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. 2020;35(47):e418. doi:10.3346/jkms.2020.35.e418</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021;4(9):e2127403. doi:10.1001/jamanetworkopen.2021.27403</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Wang W, Shi X, et al. Seroepidemiology of pertussis in the east of China: estimates of incidence of infection in adolescents and adults pre- and post-COVID-19. Front Public Health. 2022;10:1054617. doi:10.3389/fpubh.2022.1054617</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1054617</ArticleId><ArticleId IdType="pmc">PMC9754053</ArticleId><ArticleId IdType="pubmed">36530663</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang YF, Han JY, Ren AM, et al. Assessment of long-term effects on pulmonary functions between severe and non-severe convalescent COVID-19 patients: a single-center study in China. J Inflamm Res. 2022;15:4751&#x2013;4761. doi:10.2147/JIR.S371283</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S371283</ArticleId><ArticleId IdType="pmc">PMC9397529</ArticleId><ArticleId IdType="pubmed">36017172</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021;2021:21250617 doi:10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju N, Yang X, Ma X, et al. Hospitalization, interpersonal and personal factors of social anxiety among COVID-19 survivors at the six-month follow-up after hospital treatment: the minority stress model. Eur J Psychotraumatol. 2022;13(1):2019980. doi:10.1080/20008198.2021.2019980</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20008198.2021.2019980</ArticleId><ArticleId IdType="pmc">PMC8803063</ArticleId><ArticleId IdType="pubmed">35111284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Zhao YJ, Zhang QE, et al. COVID-19-related stigma and its sociodemographic correlates: a comparative study. Global Health. 2021;17(1):54. doi:10.1186/s12992-021-00705-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-021-00705-4</ArticleId><ArticleId IdType="pmc">PMC8103123</ArticleId><ArticleId IdType="pubmed">33962651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Yang X, Zheng W, et al. Depression, anxiety and post-traumatic growth among COVID-19 survivors six-month after discharge. Eur J Psychotraumatol. 2022;13(1):2055294. doi:10.1080/20008198.2022.2055294</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20008198.2022.2055294</ArticleId><ArticleId IdType="pmc">PMC8986234</ArticleId><ArticleId IdType="pubmed">35401948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z, Wu X, Zhang X, et al. The occurrence and risk factors associated with post-traumatic stress disorder among discharged COVID-19 patients in Tianjin, China. Brain Behav. 2022;12(2):e2492. doi:10.1002/brb3.2492</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2492</ArticleId><ArticleId IdType="pmc">PMC8865157</ArticleId><ArticleId IdType="pubmed">35064764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L, Fang Y, Luo D, et al. Pre-hospital, in-hospital and post-hospital factors associated with sleep quality among COVID-19 survivors 6 months after hospital discharge: cross-sectional survey in five cities in China. BJPsych Open. 2021;7(6):e191. doi:10.1192/bjo.2021.1008</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2021.1008</ArticleId><ArticleId IdType="pmc">PMC8505817</ArticleId><ArticleId IdType="pubmed">34659795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Wang YR, Wang QH, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):48. doi:10.1186/s13024-021-00469-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00469-w</ArticleId><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang YF, Liu T, Yu JN, et al. Half-year follow-up of patients recovering from severe COVID-19: analysis of symptoms and their risk factors. J Intern Med. 2021;290(2):444&#x2013;450. doi:10.1111/joim.13284</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13284</ArticleId><ArticleId IdType="pmc">PMC8242565</ArticleId><ArticleId IdType="pubmed">33904618</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Li Y, Li J, et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021;6(5):344&#x2013;346. doi:10.1016/S2468-1253(21)00076-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(21)00076-5</ArticleId><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>General Office of the National Health Commission(China), Rehabilitation Program for discharged COVID-19 Patients (Trial). Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202003/d4558d2cc35e44d5b9adba7c911e0b4c.shtml. Accessed March
4, 2020.</Citation></Reference><Reference><Citation>Kim Y, Kim SE, Kim T, et al. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect Chemother. 2022;54(3):566&#x2013;597. doi:10.3947/ic.2022.0141</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2022.0141</ArticleId><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi:10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi:10.1038/s41467-021-27797-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Liu Z, Tang L, et al. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021;18(1):29&#x2013;41. doi:10.7150/ijms.49728</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.49728</ArticleId><ArticleId IdType="pmc">PMC7738960</ArticleId><ArticleId IdType="pubmed">33390771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi:10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvisi M, Ferrozzi F, Balzarini L, Mancini C, Ramponi S, Uccelli M. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution. Int J Infect Dis. 2020;99:485&#x2013;488. doi:10.1016/j.ijid.2020.08.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.054</ArticleId><ArticleId IdType="pmc">PMC7443096</ArticleId><ArticleId IdType="pubmed">32841688</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi:10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanthan S, Patil S, Subramaniam N, Sharma R. COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey. Vaccines. 2021;9(10):1064. doi:10.3390/vaccines9101064</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101064</ArticleId><ArticleId IdType="pmc">PMC8537475</ArticleId><ArticleId IdType="pubmed">34696172</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew RF, Preiss AJ, et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023;14(1):2914. doi:10.1038/s41467-023-38388-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12422. doi:10.3390/ijerph191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China. The dynamics of epidemic prevention and control. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202109/bf2cf785ce0544ae818a76ffbb18ca79.shtml. Accessed September
19, 2021.</Citation></Reference><Reference><Citation>Umakanthan S, Bukelo MM, Gajula SS. The Commonwealth Caribbean COVID-19: regions resilient pathway during pandemic. Front Public Health. 2022;10:844333. doi:10.3389/fpubh.2022.844333</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.844333</ArticleId><ArticleId IdType="pmc">PMC9160791</ArticleId><ArticleId IdType="pubmed">35664108</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanthan S, Lawrence S. Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. Postgrad Med J. 2022;98(1164):756&#x2013;764. doi:10.1136/postgradmedj-2021-141365</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-141365</ArticleId><ArticleId IdType="pubmed">37062994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li Y, Yue Y, et al. Adherence to healthy lifestyle prior to infection and risk of post-COVID-19 condition. JAMA Intern Med. 2023;183(3):232&#x2013;241. doi:10.1001/jamainternmed.2022.6555</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.6555</ArticleId><ArticleId IdType="pmc">PMC9989904</ArticleId><ArticleId IdType="pubmed">36745445</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xia W, Zhan C, et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax. 2022;77(7):697&#x2013;706. doi:10.1136/thoraxjnl-2021-217382</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217382</ArticleId><ArticleId IdType="pmc">PMC8318721</ArticleId><ArticleId IdType="pubmed">34312316</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Qiao D, Xu Y, et al. The efficacy of computerized cognitive behavioral therapy for depressive and anxiety symptoms in patients with COVID-19: randomized controlled trial. J Med Internet Res. 2021;23(5):e26883. doi:10.2196/26883</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26883</ArticleId><ArticleId IdType="pmc">PMC8128049</ArticleId><ArticleId IdType="pubmed">33900931</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li X, Jiang J, et al. The effect of cognitive behavioral therapy on depression, anxiety, and stress in patients with COVID-19: a randomized controlled trial. Front Psychiatry. 2020;11:580827. doi:10.3389/fpsyt.2020.580827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.580827</ArticleId><ArticleId IdType="pmc">PMC7661854</ArticleId><ArticleId IdType="pubmed">33192723</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Yang L, Zhu X, et al. Mental health chatbot for young adults with depressive symptoms during the COVID-19 pandemic: single-blind, three-arm randomized controlled trial. J Med Internet Res. 2022;24(11):e40719. doi:10.2196/40719</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/40719</ArticleId><ArticleId IdType="pmc">PMC9680932</ArticleId><ArticleId IdType="pubmed">36355633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C, Buse JB, Liebovitz D, et al. Outpatient treatment of COVID-19 and the development of long COVID Over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial. Lancet. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>EINPRESSWIRE. Adult stem cell therapy for COVID-19 sequelae begins in Japan for the first time in the world; 2020. Available from: https://www.einpresswire.com/article/532284733/adult-stem-cell-therapy-for-covid-19-sequelae-begins-in-japan-for-the-first-time-in-the-world. Accessed December
08, 2020.</Citation></Reference><Reference><Citation>Shi L, Yuan X, Yao W, et al. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2022;75:103789 doi:10.1016/j.ebiom.2021.103789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103789</ArticleId><ArticleId IdType="pmc">PMC8709782</ArticleId><ArticleId IdType="pubmed">34963099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12(1):11252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J, Hires C, Keenan L, Dunne E. Aromatherapy blend of thyme, Orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: a randomized, double-blinded, placebo controlled clinical trial. Complement Ther Med. 2022;67:102823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949693</ArticleId><ArticleId IdType="pubmed">35341944</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascanio L, Vitelli F, Cingolani C, Maranzano M, Brenner MJ, Di Stadio A. Randomized clinical trial &#x201c;olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin&#x201d;: preliminary results. Eur Rev Med Pharmacol Sci. 2021;25(11):4156&#x2013;4162.</Citation><ArticleIdList><ArticleId IdType="pubmed">34156697</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70(1):61&#x2013;67. doi:10.1136/jim-2021-002051</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto MD, Lambert N, Downs CA, et al. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J Nurse Pract. 2022;18(3):335&#x2013;338 doi:10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z, Dautaj A, Nodari S, et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur Rev Med Pharmacol Sci. 2021;25(1 Suppl):67&#x2013;73 doi:10.26355/eurrev_202112_27335.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27335</ArticleId><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanthan S, Senthil S, John S, et al. The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study. Front Pharmacol. 2022;13:742273. doi:10.3389/fphar.2022.742273</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.742273</ArticleId><ArticleId IdType="pmc">PMC9294274</ArticleId><ArticleId IdType="pubmed">35865966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>